Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 416 (OTC: $CSUI)
(OTC: $SIML) (CSE: $MWM.C) (TSXV:
$KHRN.V) (OTCQX: $KHRNF) (CSE: $THC.C)
(OTC: $THCBF)
Delta, Kelowna, BC, May 20, 2020 (Investorideas.com Newswire)
www.Investorideas.com, a global news source covering leading sectors including
marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2020/cannabis-potcasts/05201CSUI-SIML-MWM-KHRN-THC.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
Today’s
podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI), a research & development company licensed
under Swiss Cannabis and tobacco regulations to cultivate and sell cannabis.
The Company's facilities for producing cannabis are based in Zurich.
The
Company grows high quality, organic cannabis with sustainable, all-natural principles.
Cannabis Suisse products are laboratory tested to ensure the end users have
access to a standardized, safe and consistent product.
In
today’s podcast we will be looking at a few public company announcements.
Simlatus
Corporation (OTC: SIML) announced today that the company has completed
its testing and will move forward with Proscere Bioscience’s CBD coldwater
extraction systems and initial $20M in orders.
Under
COVID19 rules, the company audit for the year ending 12/31/2019 is completed
and scheduled for filing, and the quarter ending 3/31/2020 will follow shortly.
Richard
Hylen, CEO, stated, “The Company has endured the COVID19, and can proceed
forward in 2 weeks in completing CBD coldwater extraction purchase orders. We
have new interest from commercial players in the CBD industry who is now
seeking quotes. Proscere Bioscience will spearhead the revenue for our company.
Our subsidiaries, Satel and our Simlatus broadcast systems, continue to produce
revenue as a part of our diversification. All of our companies show extreme
promise in growing revenues this year.”
The
company operates multiple revenue streams in the CBD Industry, Major Broadcast
Industry and Internet Provider Industry. Proscere Bioscience manufactures the
first commercial industry standard cold-water CBD extraction system for medical
grade cannabis utilization, along with their aeroponic commercial grade
technology control containers for government food-safety programs, commercial
and medical grade CBD. Satel Group is the premier high-rise DirecTV providers
in the San Francisco metropolitan area, and is now expanding both DirecTV and
Internet services across the SF Bay Area. Simlatus manufactures its own
proprietary systems for the major broadcast studios, such as Warner Bros., Fox
News, CBS and DirecTV. Its video technology is the major system used for
underwater oil exploration in the world.
Micron Waste
Technologies Inc. (CSE: MWM) (OTC: MICWF) announced that it has entered into a
Definitive Purchase Agreement with the shareholders of Covid Technologies Inc.
for the acquisition of all of the shares of Covid.
Since
announcing the interim agreement with Covid on April 20, 2020, the Company has
been completing diligence on Covid, the personal protection equipment
("PPE") industry and anticipated demand for PPE. The Company is of the view that the demand
for PPE will increase in the future as Canadian and worldwide economies,
education and securities re-open. The
anticipated demand for PPE the Company believes will transcend the current need
arising from the pandemic and will become a requirement of the "new
normal". Covid has established
manufacturing capacity through the acquisition of state-of-the-art mask making
equipment, including the purchase of a FLK120 surgical mask making machine and
over 5 tonnes of raw material for mask production. Covid has additional cash and manufacturing
assets having a replacement value of approximately $500,000. Since the interim agreement, Covid has
entered into purchase agreements for approximately 1 million masks to private
enterprise.
Following
closing of the purchase and sale, Covid will relocate its manufacturing
facilities to the Delta, BC facilities of Micron and be managed by the existing
Micron team, together with Covid founder Harveer Sidhu.
Micron
will continue the research and development of its Cannavore, Pharmavore and
Organivore waste digesters from its Delta facilities. In particular, the Pharmavore digestor is
anticipated to enter testing and trials with an industry partner in Q2 2020.
The
Company has in excess of $3M to allocate to its waste digestor business and it
is anticipated that the PPE business line will be self-financing based on
anticipated sales.
Closing
of the acquisition is anticipated to be completed by the end of May 2020.
Khiron Life
Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) announced that it has received authorization
from Colombia's National Narcotics Fund for the sale of magistral preparation
of high-THC medical cannabis. With this authorization Khiron becomes the first
and, to date, only company fully authorized to manufacture and sell high-THC
medical cannabis for patient prescriptions in Colombia.
"The
authorization from Colombia's National Narcotics Fund demonstrates our
continued ability to meet regulatory requirements, and as a result we today
begin to sell high-THC medical cannabis product in Colombia. With our clinics,
training and infrastructure in place our high-THC product offers an important
alternative for patients living with chronic pain, nausea and vomiting
associated with chemotherapy, and continues Khiron's mission to improve the
quality of life for patients in Colombia and across Latin America,"
comments Juan Diego Alvarez, Khiron Vice-President of Regulatory Affairs.
Initial
high-THC product prescriptions under the National Narcotics Fund authorization
will be filled through the Company's fully owned ILANS clinics which are in
receipt of high-THC dispensary authorization. Distribution will expand as
Khiron's Colombian pharmacy partners receive dispensing authorization, which is
anticipated in Q3 2020.
THC BioMed Intl
Ltd. (CSE:THC) (OTC:THCBF) announced that it will begin this week to ship
its ready-to-drink Cannabis Beverage Shot, THC KISS, to the legal adult
recreational cannabis market.
THC
BioMed's first shipment of THC Kiss will head to Saskatchewan, with shipments
to B.C. and Ontario currently undergoing fulfilment.
THC
KISS is a brand new Cannabis Beverage Shot that promises to offer a different
experience compared to edibles and beverages currently available in either the
grey or legal cannabis markets.
THC
Kiss aims to be an alternative to smoking cannabis and was developed by THC
BioMed using proprietary extraction methods invented by THC BioMed.
"We
have received very positive feedback on THC Kiss from our medical patients,
with repeat orders per client increasing substantially. We are proud to bring
Canadians a true alternative to smoking cannabis," commented John Miller,
President and CEO.
Each
30ml bottle of THC Kiss contains 10 mg of THC.
Once
again, today’s podcast was sponsored by Cannabis Suisse Corp. (OTC: CSUI), a research & development company licensed
under Swiss Cannabis and tobacco regulations to cultivate and sell cannabis.
The Company's facilities for producing cannabis are based in Zurich.
The
Company grows high quality, organic cannabis with sustainable, all-natural
principles. Cannabis Suisse products are laboratory tested to ensure the end
users have access to a standardized, safe and consistent product.
Investor
ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com
website and this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts
and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech,
water, renewable energy and more. Investor Idea’s original branded content
includes the following podcasts and columns : Crypto
Corner , Play by Play sports and stock news column, Investor
Ideas Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investing involves risk and possible losses.
This site is currently compensated for news publication and distribution,
social media and marketing, content creation and more. Disclosure is posted for
each compensated news release, content published /created if required but
otherwise the news was not compensated for and was published for the sole
interest of our readers and followers. Contact management and IR of each
company directly regarding specific questions. Disclosure- CSUI is a paid
monthly news and social media client /More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our
other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to
regulations of each country. Please read Investorideas.com privacy
policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor
Ideas – news, articles, podcasts and stock
directory
